V. Santini

发表论文 96 篇 · 总被引 527 次 · h-index 11

代表论文

• Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT. (2025 · Blood · 被引 24)
• Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes (2025 · Journal of Clinical Oncology · 被引 12)
• Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial (2025 · Advances in Therapy · 被引 6)
• Imetelstat improves patient-reported outcomes and quality of life in lower-risk myelodysplastic syndromes: results from the phase III IMerge study (2026 · Haematologica · 被引 2)
• Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS (2025 · Blood Cancer Journal · 被引 2)
• Psychometric properties and meaningful change thresholds for the QOL-E instrument in patients with myelodysplastic neoplasms (2025 · Frontiers in Oncology · 被引 2)